Relationship between glomerular hyperfiltration and ACE insertion/deletion polymorphism in type 1 diabetic children and adolescents

Diabetes Care

Volumn 22, Issue 4, 1999, Pages 618-622

  Bouhanick, Beatrict ^a   Gallois, Yvis ^a   Hadjadj, Samy ^a   De Casson, Florence Boux ^a   Limal, Jean Marie ^a   Marre, Michel ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DELETION MUTANT; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; ENZYME ASSAY; ENZYME BLOOD LEVEL; ENZYME POLYMORPHISM; FEMALE; GENE INSERTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GLOMERULUS FILTRATION; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PREDICTION; RISK FACTOR;

EID: 0033034806     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.4.618     Document Type: Article

References (31)

1. Mogensen CE, Christensen CK: Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 311:89-93, 1984
2. Lervang HH, Jensen J, Brochner-Mortensen J, Ditzel J: Early glomerular hyperfiltration and the later development of nephropathy in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 31:723-729, 1988
3. Jones SL, Wiseman MJ, Viberti GC: Glomerular hyperfiltration as a risk factor for diabetic nephropathy: 5-year report of a prospective study. Diabetologia 34:59-65, 1991
4. Yip JW, Jones SL, Wiseman MJ, Hill C, Viberti GC: Glomerular hyperfiltration in the prediction of nephropathy in IDDM: a 10-year follow-up study. Diabetes 45:1729-1733, 1996
5. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F: An insertion deletion polymorphism in angiotensin I convertion enzyme gene accounting for half of the variance of serum enzyme levels. J Clin Invest 86:1343-1346, 1990
6. Alhenc-Gelas F, Baussant T, Hubert C, Soubrier F, Corvol P: The angiotensin I converting enzyme in the kidney. J Hypertens 7:S9-S13, 1989
7. Marre M, Bernardet P, Gallois Y, Savagner F, Guyenne TT, Hallab M, Cambien F, Passa P, Alhenc-Gelas F: Relationship between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 43:384-388, 1994
8. Marre M, Jeunemaitre X, Gallois Y, Rodier M, Chatellier G, Sert C, Dusselier L, Kahal Z, Chaillous L, Halimi S, Muller A, Sackmann H, Bauduceau B, Bled F, Passa P, Alhenc-Gelas F: Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes. J Clin Invest 99:1585-1595, 1997
9. Staessen JA, Wang JG, Ginocchio G, Petrov V, Saavedra AP, Soubrier F, Vlietinck R, Fagard R: The deletion/insertion polymorphism of the angiotensin-converting enzyme gene and cardiovascular renal risk. J Hypertens 15:1579-1592, 1997
10. Fujisawa T, Ikegami H, Kawaguchi Y, Hamada Y, Ueda H, Shintani M, Fukuda M, Ogihara T: Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy. Diabetologia 41:47-53, 1998
11. Monnier L, Slama G, Vialettes B, Ziegler O: ALFEDIAM recommendations: Nutrition and Diabetes. Diabete Metab 21:207-216, 1995
12. Brochner-Mortensen J: A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest 30:271-274, 1972
13. 51Cr-EDTA. Clin Sci 37:169-175, 1969
14. Marre M, Hallab M, Roy J, Le Jeune JJ, Jallet P, Fressinaud P: Glomerular hyperfiltration in type I, type II and secondary diabetes. J Diabetes Complications 6:19-24, 1992
15. Marre M, Claudel JP, Ciret P, Luis N, Suarez L, Passa P: Laser immunonephelometry for routine quantification of urinary albumin excretion. Clin Chem 33:209-213, 1987
16. Bouhanick B, Berrut G, Chameau AM, Hallab M, Bled F, Chevet B, Vergely J, Rohmer V, Fressinaud P, Marre M: Predictive value of testing random urine sample to detect microalbuminuria in diabetic subjects during out-patient visits. Diabetes Metab 18:54-58, 1992
17. Fabiny DL, Eertingshausen G: Automated reaction rate method for determination of serum creatinine with the Centrichem. Clin Chem 17:696-700, 1971
18. Goldstein DE, Little RR, England JD, Wiedmeyer HM, McKensie EM: Methods for quantitating glycosylated hemoglobins: high-performance liquid chromatography and thiobarbituric acid colorimetry. In Methods in Diabetes Research. vol. 2, Clinical Methods. Clarke WL, Larner J, Pohl SL, Eds. New York, Wiley, 1986, p. 475-504
19. Danilov S, Savoie F, Lenoir B, Jeunemaitre X, Azizi M, Tarnow L, Alhenc-Gelas F: Development of enzyme-linked immunoassays for human angiotensin I converting enzyme suitable for large-scale studies. J Hypertens 14:719-727, 1996
20. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Lecerf L, Poirier O, Danilov S, Parving HH: Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 44:489-494, 1995
21. Rudberg S, Persson B, Dahlquist G: Increased glomerular filtration rate as a predictor of diabetic nephropathy: an 8-year prospective study. Kidney Int 41:822-828, 1992
22. Woods LL: Mechanisms of renal hemodynamic regulation in response to protein feeding. Kidney Int 44:659-675, 1993
23. Dahlquist G, Aperia A, Broberger O, Persson B, Wilton P: Renal function in relation to metabolic control in children with diabetes of different duration. Acta Paediatr Scand 72:903-909, 1983
24. Levy-Marchal C, Laborde K, Kindermans C, Dechaux M, Czernichow P: Persisting glomerular hyperfiltration in short term diabetic children without microalbuminuria. Acta Pediatric Scand 78:712-716, 1989
25. The SOLVD Investigators: Effects of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325: 293-302, 1991
26. Marre M, Leblanc H, Juarez L, Guyenne TT, Menard J, Passa P: Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent microalbuminuria. Br Med J 294:1448-1452, 1987
27. Mau-Pedersen M, Schmitz A, Pedersen EB, Danielsen H, Christiansen JS: Acute and long-term renal effects of angiotensin converting enzyme inhibition in normotensive, normoalbuminuric insulin-dependent diabetic patients. Diabet Med 5:562-569, 1988
28. Miller JA, Scholey JW, Thai K, Pei YPC: Angiotensin converting enzyme gene polymorphism and renal hemodynamic function in early diabetes. Kidney Int 51:119-124, 1997
29. Fukumoto S, Ishimura E, Hosoi M, Kawagishi T, Kawamura T, Isshiki G, Nishizawa Y, Morii HA: Angiotensin converting enzyme gene polymorphism and renal artery resistance in patients with insulin dependent diabetes mellitus. Life Sci 59:629-637, 1996
30. Brenner BM: Hemodynamicaly mediated glomerular injury and the progressive nature of kidney disease. Kidney Int 23: 617-655, 1983
31. Osterby R, Parving HH, Hommel E, Jorgensen HE, Lokkegard H: Glomerular structure and function in diabetic nephropathy. Diabetes 39: 1057-1063, 1990